Event JSON
{
"id": "55cfb6effe500d913bc945cc3df5230b5d741c3fe47bd6f73ee8857738f1101a",
"pubkey": "a09a081c39538be74c33fc480aac4154cee09142a066fbfebab4cfba2722fb4a",
"created_at": 1739184133,
"kind": 1,
"tags": [
[
"r",
"https://www.calcalist.co.il/local_news/article/hjv67upyye"
],
[
"subject",
"The Pharmaceutical Committee presents: A prescription for the wealthy only"
],
[
"published_at",
"1739180177"
],
[
"image",
"https://pic1.calcalist.co.il/picserver3/crop_images/2025/02/10/S1I1LUwYkx/S1I1LUwYkx_0_0_1777_1001_0_large.jpg"
],
[
"p",
"a09a081c39538be74c33fc480aac4154cee09142a066fbfebab4cfba2722fb4a",
"wss://articles.layer3.news"
],
[
"imeta",
"url https://pic1.calcalist.co.il/picserver3/crop_images/2025/02/10/S1I1LUwYkx/S1I1LUwYkx_0_0_1777_1001_0_large.jpg"
],
[
"t",
"Israel:perspective"
],
[
"summary",
"The decision has raised concerns about the widening gap in healthcare access between the rich and the poor in Israel. The medications, which are priced between 450-1,744 shekels per month, are not covered by the public health insurance system, leaving low-income individuals without access to treatment. The decision has been criticized by healthcare professionals, who argue that it will exacerbate health disparities and worsen the already dire situation for those struggling with obesity."
]
],
"content": "nostr:nprofile1qyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq5zdqs8pe2w97wnpnl3yq4tzp2n8wpy2z5pn0hl46kn8m5fezld9q8vm2lw\nhttps://pic1.calcalist.co.il/picserver3/crop_images/2025/02/10/S1I1LUwYkx/S1I1LUwYkx_0_0_1777_1001_0_large.jpg\nThe committee's decision to remove the weight management medications from the list will further exacerbate the existing health disparities in the population, and will likely lead to the development of a 'gray market' for these medications.\nhttps://www.calcalist.co.il/local_news/article/hjv67upyye",
"sig": "694de83df89b3a46f4117a4e3c3905005ed32ddf43b2d47019ebe0a2fc2194a9f5b4799531464bb7339a4d074bbcbe3e5867902ec5536bed6902ab1a0155965b"
}
